Christoph Eilenberger
Overview
Explore the profile of Christoph Eilenberger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rothbauer M, Eilenberger C, Spitz S, Bachmann B, Kratz S, Reihs E, et al.
Front Bioeng Biotechnol
. 2022 Mar;
10:837087.
PMID: 35252144
The re-creation of physiological cellular microenvironments that truly resemble complex architectures is the key aspect in the development of advanced organotypic tissue constructs. Among others, organ-on-a-chip technology has been increasingly...
2.
Eilenberger C, Rothbauer M, Brandauer K, Spitz S, Ehmoser E, Kupcu S, et al.
Pharmaceutics
. 2022 Feb;
14(2).
PMID: 35214071
Stem cell technology and embryonic stem cell models are of great interest in biomedical research since they provide deeper insights into, e.g., neurogenesis and early mammalian brain development. Despite their...
3.
Eilenberger C, Rothbauer M, Selinger F, Gerhartl A, Jordan C, Harasek M, et al.
Adv Sci (Weinh)
. 2021 Jun;
8(11):e2004856.
PMID: 34105271
Physiological-relevant in vitro tissue models with their promise of better predictability have the potential to improve drug screening outcomes in preclinical studies. Despite the advances of spheroid models in pharmaceutical...
4.
Rothbauer M, Bachmann B, Eilenberger C, Kratz S, Spitz S, Holl G, et al.
Micromachines (Basel)
. 2021 Apr;
12(5).
PMID: 33919242
Organ-on-a-chip technology has the potential to accelerate pharmaceutical drug development, improve the clinical translation of basic research, and provide personalized intervention strategies. In the last decade, big pharma has engaged...
5.
Eilenberger C, Selinger F, Rothbauer M, Lin Y, Limbeck A, Schadl B, et al.
ACS Pharmacol Transl Sci
. 2021 Feb;
4(1):101-106.
PMID: 33615164
Both cerium oxide (CeOx) nanoparticles and mefenamic acid (MFA) are known anti-inflammatory agents with hepatoprotective properties and are therefore prescribed for one of the major diseases in the world, nonalcoholic...
6.
Rothbauer M, Eilenberger C, Spitz S, Bachmann B, Pajenda J, Schwaighofer A, et al.
Spectrochim Acta A Mol Biomol Spectrosc
. 2020 May;
237:118388.
PMID: 32361318
Glucose transport is key for cellular metabolism as well as physiological function and is maintained via passive facilitated and active sodium-glucose linked transport routes. Here, we present for the first...
7.
Rothbauer M, Holl G, Eilenberger C, Kratz S, Farooq B, Schuller P, et al.
Lab Chip
. 2020 Mar;
20(8):1461-1471.
PMID: 32219235
Rheumatoid arthritis is a chronic, systemic joint disease in which an autoimmune response translates into an inflammatory attack resulting in joint damage, disability and decreased quality of life. Despite recent...
8.
Schuller P, Rothbauer M, Eilenberger C, Kratz S, Holl G, Taus P, et al.
MethodsX
. 2019 Nov;
6:2606-2613.
PMID: 31763193
Structured metal thin-film electrodes are heavily used in electrochemical assays to detect a range of analytes including toxins, biomarkers, biological contaminants and cell cultures using amperometric, voltammetric and impedance-based (bio)sensing...
9.
Eilenberger C, Spitz S, Bachmann B, Ehmoser E, Ertl P, Rothbauer M
Micromachines (Basel)
. 2019 May;
10(5).
PMID: 31035574
Synthetic biology aims to understand fundamental biological processes in more detail than possible for actual living cells. Synthetic biology can combat decomposition and build-up of artificial experimental models under precisely...
10.
Eilenberger C, Rothbauer M, Ehmoser E, Ertl P, Kupcu S
Sci Rep
. 2019 Mar;
9(1):4863.
PMID: 30890741
The enhanced predictive power of 3D multi-cellular spheroids in comparison to conventional monolayer cultures makes them a promising drug screening tool. However, clinical translation for pharmacology and toxicology is lagging...